Disease/Infection News

RSS

In the COVID age, bring a mask and gloves to a protest

When Lamari Edwards joined Dreasjon "Sean" Reed's Facebook Live video, she could sense something bad was going to happen, but she never thought she was witnessing the last moments of her friend's life. "I had a bad feeling, but I did not think it would end this way," said Edwards.

18 May 2020

Drugmakers tout COVID-19 vaccines to refurbish their public image

Johnson & Johnson researchers working on a vaccine against the coronavirus are "just like the heroes in the hospitals" fighting to save patients, J&J CEO Alex Gorsky said on the "Today" show a few weeks ago.

18 May 2020

COVID-19 may lead to thrombosis in the lungs and subsequently multi organ failure

COVID-19, the disease caused by SARS-CoV-2, not only may lead to severe pneumonia but also to thrombosis in the lungs and, subsequently, to multi organ failure involving kidneys, liver and pancreas.

18 May 2020

ISE continues to support research community in the global effort to fight COVID-19

The current COVID-19 pandemic is having a huge impact on people across the globe and in these unprecedented times we consider it more important than ever that we continue to support the publication of relevant and timely research.

18 May 2020

Medicaid providers at the end of the line for federal COVID funding

Casa de Salud, a nonprofit clinic in Albuquerque, New Mexico, provides primary medical care, opioid addiction services and non-Western therapies, including acupuncture and reiki, to a largely low-income population.

18 May 2020

New biodegradable antiviral filters developed for protective masks

The CSIC's associated unit in Polymer Technology in Castellón will study the biodegradation levels of the materials developed.

18 May 2020

Researchers are developing advanced measures to fight against COVID-types contagions

A research team from the University of Valencia, led by the professor of the Department of Computer Science Pedro Morillo, is developing a project to improve protection against infections in areas of high availability of health centres.

18 May 2020

Avacta's SARS-COV-2 neutralizing Affimer reagents show therapeutic potential for COVID-19

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, is pleased to announce that several of the Affimer reagents recently generated for development of a point-of-care COVID-19 antigen saliva test have now also been shown to block the interaction between the virus’ spike protein and ACE2, a receptor on human cells that is key to the virus infection pathway.

From Avacta Life Sciences Ltd. 18 May 2020

COVID-19 clinical trials show positive early results, says GlobalData

With the number of COVID-19 cases and deaths increasing with each passing day, the need for a therapeutic or a vaccine for the pandemic intensifies.

18 May 2020

Research explores how human enzymes could be used to exacerbate COVID-19

Centenary Institute researchers have examined the critical role of human enzymes and the coronavirus in a newly published scientific review article that explores potential strategies for COVID-19 disease treatment and management.

18 May 2020

Interactive "Netflix" type platform for educators affected by COVID-19

The World Literacy Foundation announced today the development of an interactive "Netflix" type platform to equip educators with resources that have been affected by the indefinite school lockdown as a result of COVID-19.

18 May 2020

A novel approach to predict heart damage in COVID-19 patients

Johns Hopkins researchers recently received a $195,000 Rapid Response Research grant from the National Science Foundation to, using machine learning, identify which COVID-19 patients are at risk of adverse cardiac events such as heart failure, sustained abnormal heartbeats, heart attacks, cardiogenic shock and death.

18 May 2020

Oxford University vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

As the world continues to grapple with the coronavirus pandemic, many scientists, institutions, and pharmaceutical companies are working hard to develop an effective vaccine.

18 May 2020

Protective Film Solutions donates over 5,500 protective visors to key workers

Suppliers of protective glass window films, Protective Film Solutions, has donated more than 5,500 pieces of personal protective equipment to hospitals, care homes and other medical facilities across the country, to prevent the spread of COVID-19.

18 May 2020

New model reveals the vulnerabilities of beef supply chain

An interdisciplinary team of Kansas State University researchers developed a computer simulation that revealed beef supply chain vulnerabilities that need safeguarding -- a realistic concern during the COVID-19 pandemic.

18 May 2020

Kawasaki disease outbreak in children with COVID-19

The ongoing COVID-19 pandemic has marched its way to almost all parts of the world, with hundreds of thousands of deaths and over 4.5 million cases as of May 15, 2020. One saving grace has been the apparent sparing of children, though the mortality in older people is quite high.

17 May 2020

Host-virus interaction drives adaptive mutation in bat CoV related to SARS-CoVs

Virus and receptor diversity is shaped by the need to evolve advanced weaponry to facilitate virus entry and infection, on the one hand, and host resistance, on the other. A new paper published on the preprint server bioRxiv* shows how this mechanism operates in a bat coronavirus, which is related to the earlier SARS coronavirus.

17 May 2020

Staggered local re-openings could be the best COVID-19 exit strategy

When a new infectious disease appears, the lack of an effective treatment or vaccine strategy often results in the application of non-pharmacological interventions (NPIs) or containment measures, including testing for infection, tracing contacts, and isolating potential sources of infection.

17 May 2020

Inadequate vaccine and epidemic control in the US

A new paper published on the preprint server medRxiv* in May 2020 shows that vaccination must be combined with nonpharmacological interventions (NPIs) to achieve rapid and effective control of the ongoing pandemic.

17 May 2020

Researchers investigate safety of convalescent plasma for COVID-19

The current pandemic of COVID-19 seems to be slowing down in various parts of the world, but is far from controlled, as incidence rates rise in new regions. In the absence of an effective vaccine or therapeutic drug, scientists have relied on supportive medical care to treat the sick.

17 May 2020